My Fund

Loading your portfolio…

Checking your account and saved picks.

Choose a startup

Explore all 1120 companies in this selection. Research each company before making your pick.

Includes historical VC holdings. A listing does not confirm current ownership or startup stage.

VC tracking →

Showing 1–5 of 5 startups

Promise

Limited coverage

Enterprise; Fintech

Company website description

Promise helps utilities and governments power world-class relief and repayment programs that increase participation and completion rates.

First Round Capital
promise-pay.com ↗
Research Promise

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Company website description

Promise helps utilities and governments power world-class relief and repayment programs that increase participation and completion rates.

Visit promise-pay.com ↗Product description source ↗

Product source checked 31 Oct 2026

Source category

Enterprise; Fintech

Category source ↗

Checked

Published location

SF Bay Area

Location source ↗

Checked

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Chestnut

Limited coverage

Company website description

Discover a family of features purpose-built for insurance. Say goodbye to legacy architecture and functionality compromises.

Andreessen Horowitz
chestnutai.com ↗
Research Chestnut

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Company website description

Discover a family of features purpose-built for insurance. Say goodbye to legacy architecture and functionality compromises.

Visit chestnutai.com ↗Product description source ↗

Product source checked 31 Oct 2026

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Eclypsium, Inc.

Collecting history

Company website description

Eclypsium’s infrastructure assurance platform protects mission critical hardware and detects compromised devices in enterprises and government agencies.

Andreessen Horowitz
eclypsium.com ↗
Research Eclypsium, Inc.

Tracking coverage

First reading saved. Waiting for a later comparable reading.

Momentum +1 · Collecting history
First reading saved. Waiting for a later comparable reading.Last reading:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Company website description

Eclypsium’s infrastructure assurance platform protects mission critical hardware and detects compromised devices in enterprises and government agencies.

Visit eclypsium.com ↗Product description source ↗

Product source checked 31 Oct 2026

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

GreyNoise

Collecting history

Company website description

The network edge is your blind spot. GreyNoise delivers real-time threat intelligence to detect active exploitation, uncover compromised devices, and investigate attacks as they happen.

CRV
greynoise.io ↗
Research GreyNoise

Tracking coverage

First reading saved. Waiting for a later comparable reading.

Momentum +1 · Collecting history
First reading saved. Waiting for a later comparable reading.Last reading:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Company website description

The network edge is your blind spot. GreyNoise delivers real-time threat intelligence to detect active exploitation, uncover compromised devices, and investigate attacks as they happen.

Visit greynoise.io ↗Product description source ↗

Product source checked 31 Oct 2026

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Orca Bio

Limited coverage

Company website description

Orca Bio is helping to deliver the promise of cell therapy to patients without compromise.

Felicis
orcabio.com ↗
Research Orca Bio

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Company website description

Orca Bio is helping to deliver the promise of cell therapy to patients without compromise.

Visit orcabio.com ↗Product description source ↗

Product source checked 31 Oct 2026

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗
How it works

Pick up to 50 companies. Your picks are private to your account.

A new US fundraising disclosure (Form D) earns 2 points. A first investment announced by a tracked VC earns 3. Milestones must occur and be observed after your pick.

Measured growth earns 1 point once: the same RiseFinder composite score rises between dated observations after your pick, using one formula version. Where available, a supported public source metric can also qualify. Lower ranks are better; rising counts are better. A completed, dated IPO or acquisition earns 10 points once.

The composite score measures relative public signals on a 0–100 scale. It is not a company valuation. Coverage varies; companies without qualifying history wait for evidence.

Initial imports, old discoveries, follow-ons from existing backers, amendments, undated events and same-day events earn no points.

Points track verified milestones after your pick. They do not represent investment returns.